男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Med-tech MNCs see healthy market space

China Daily | Updated: 2022-11-11 09:38
Share
Share - WeChat
Bian Xin, CEO of Roche Pharmaceuticals China

A1 In the past five years, the CIIE has become a very important stage for the debut of global innovative products and cutting-edge technologies, and it has also built an excellent platform for communications and exchanges between the government and enterprises, and between enterprises.

The 20th National Congress of the Communist Party of China just closed. We believe the opening of the fifth CIIE at this point fully demonstrates the country's commitment to achieving high-quality economic development and its new strides in reform and opening-up.

We believe that the convening of the CIIE will provide more "Chinese opportunities" for the rest of the world. Roche is encouraged, with stronger confidence in and commitment to the Chinese market.

A2 It's a great honor for Roche to attend the CIIE for five consecutive years. With one of the largest booth areas in the medical and healthcare pavilion, Roche highlights a full portfolio of launched and market-ready products at its 1,000-square-meter booth, including nearly 10 global innovative products that will soon be launched in China, covering major disease areas such as hematological tumors, breast cancer, ophthalmology and neuroscience.

At the expo, Roche holistically showcases multiple innovative projects and solutions. We hope to leverage the CIIE as a bridge to align with the Chinese government and partners in enhancing exchange and collaboration, seeking synergies in resources to foster industry development, and jointly building, creating and sharing the healthcare ecosystem in China.

A3 In recent years, we have seen that China has further deepened reform, which has unleashed more market vitality and economic resilience. Recently, a series of policies have been introduced to help increase, stabilize and improve the quality of foreign investment. We firmly believe that these positive measures will further boost our confidence in continuing to deepen our business in China, increase our business in China and invest in China.

A4 China has become the world's second-largest pharmaceutical market. Global companies like Roche have benefited from the country's opening-up and economic reform, which has led to a favorable business environment and easier market access.

In the healthcare sector, we have seen significant improvements in policies and measures to accelerate the regulatory approval and affordability of innovative drugs in recent years, to promote the transformation and upgrading of the industry and the high-quality development of the economy and society. We are also heartened to see that the government places a strategic priority on ensuring people's health and improving policies for promoting public health, which shows the government's commitment to elevating the health and well-being of the Chinese people.

|<< Previous 1 2 3 4 5 6 7 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 镇巴县| 郁南县| 兴海县| 永州市| 沧源| 乌海市| 凯里市| 饶平县| 班玛县| 昌吉市| 右玉县| 舞钢市| 兴山县| 巫山县| 龙南县| 蓬安县| 喜德县| 永胜县| 钦州市| 通许县| 宜春市| 于都县| 中卫市| 嘉鱼县| 东乡县| 密云县| 安多县| 宁陵县| 阜阳市| 桦甸市| 井研县| 建瓯市| 四平市| 遂溪县| 义马市| 河北区| 平阴县| 肃南| 南昌县| 晋中市| 漳平市|